There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SQZ Biotechnologies (SQZ – Research Report) and AVEO Pharma (AVEO – Research Report) with bullish sentiments. SQZ Biotechnologies (SQZ) Brookline Capital Markets analyst Leah R. Cann maintained a Buy rating on SQZ Biotechnologies today and set a price target of $42.00. The company's shares closed last Tuesday at $3.20, close to its 52-week low of $2.73. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sqz-biotechnologies-sqz-and-aveo-pharma-aveo?utm_source=advfn.com&utm_medium=referral
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more AVEO Pharmaceuticals Charts.
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more AVEO Pharmaceuticals Charts.